欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

GSK Cuts Costs With Phase III Starts Set To Double

2026-07-30
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%

2026-07-30
European Commission Backs Member States As MFN Pressure Builds

2026-07-30
‘Dubious Clinical Value’: Spain Sees Future Role For Alzheimer’s Drugs Despite Funding Rejection

2026-07-30
Brazilian Semaglutide Competition Hots Up With Sandoz-Adalvo Approval

2026-07-30
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

2026-07-29
Cipla Joins Generic Advair Club With FDA Approval

2026-07-29
On behalf of Respighi BidCo S.p.A – Press Release pursuant to art. 38, para 2, of the Issuers’ Regulation – Publication of the Offer Document

2026-07-29
GSK Cuts Costs With Phase III Starts Set To Double

2026-07-29
Biocon Malaysia Receives EMA Approval for New Drug Product Fill Finish Unit for Insulins

2026-07-29
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026

2026-07-28
MAD World Summit 2026

2026-07-28